78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.
Qualys Q4 EPS $0.84 Beats $0.80 Estimate, Sales $109.78M Beat $108.43M Estimate
Qualys (NASDAQ:QLYS) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.80 by 5 percent. This is a 18.31 percent increase over earnings of $0.71 per share from the same period
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell
• Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Expert Ratings For Qualys
Qualys (NASDAQ:QLYS) has observed the following analyst ratings within the last quarter:
Summit Insights Group Upgrades Qualys to Buy
Summit Insights Group analyst Srini Nandury upgrades Qualys (NASDAQ:QLYS) from Hold to Buy.
JP Morgan Upgrades Qualys to Overweight, Raises Price Target to $160
JP Morgan analyst Sterling Auty upgrades Qualys (NASDAQ:QLYS) from Underweight to Overweight and raises the price target from $110 to $160.
Morgan Stanley Maintains Underweight on Qualys, Raises Price Target to $110
Morgan Stanley maintains Qualys (NASDAQ:QLYS) with a Underweight and raises the price target from $100 to $110.
RBC Capital Maintains Sector Perform on Qualys, Raises Price Target to $128
RBC Capital analyst Matthew Hedberg maintains Qualys (NASDAQ:QLYS) with a Sector Perform and raises the price target from $112 to $128.
Qualys Q3 EPS $0.86 Beats $0.79 Estimate, Sales $104.93M Beat $104.11M Estimate
Qualys (NASDAQ:QLYS) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.79 by 8.86 percent. This is a 11.69 percent increase over earnings of $0.77 per share from the same
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.